Recurrent vulvovaginal candidiasis: could it be related to cell-mediated immunity defect in response to candida antigen?
IJFS-International Journal of Fertility and Sterility. 2017; 11 (3): 134-141
in En
| IMEMR
| ID: emr-192309
Responsible library:
EMRO
ABSTRACT
Background:
Recurrent vulvovaginal candidiasis [RVVC] is a common cause of morbidity affecting millions of women worldwide. Patients with RVVC are thought to have an underlying immunologic defect. This study has been established to evaluate cell-mediated immunity defect in response to Candida antigen in RVVC cases
Search on Google
Index:
IMEMR
Language:
En
Journal:
Int. J. Fertil. Steril.
Year:
2017